Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Adiuvo Investments's Debt-to-Equity or its related term are showing as below:
WAR:ADV'
s Debt-to-Equity Range Over the Past 10 Years
Min: -8.97 Med: 0.08 Max: 126.23
Current: -0.71
During the past 13 years, the highest Debt-to-Equity Ratio of Adiuvo Investments was 126.23. The lowest was -8.97. And the median was 0.08.
WAR:ADV's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.23
vs WAR:ADV: -0.71
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Adiuvo Investments Debt-to-Equity Related Terms
Adiuvo Investments Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Adiuvo Investments's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:ADV vs ABT, SYK, MDT: Debt-to-Equity Comparison
For the Medical Devices subindustry, Adiuvo Investments's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adiuvo Investments Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adiuvo Investments's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Adiuvo Investments's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adiuvo Investments (WAR:ADV) has a Debt-to-Equity of -0.71 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Adiuvo Investments and its competitors. According to the industry distribution chart, Adiuvo Investments ranks #999999 out of 699 companies in the Medical Devices & Instruments industry.
Is Adiuvo Investments' Debt-to-Equity too high?
Adiuvo Investments' current Debt-to-Equity is -0.71. Based on the distribution chart, Adiuvo Investments ranks #999999 out of 699 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adiuvo Investments has a GF Score™ of 26/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Adiuvo Investments' Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Adiuvo Investments ranks #999999 out of 699 companies for Debt-to-Equity. This places Adiuvo Investments in the lower half of its industry. The industry median Debt-to-Equity is 0.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Adiuvo Investments and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adiuvo Investments's current Debt-to-Equity is -0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adiuvo Investments stock overvalued right now?
Based on GuruFocus' analysis, Adiuvo Investments (WAR:ADV) is currently considered Modestly Overvalued. The stock's GF Value™ is zł0.47, compared to a current price of zł0.53 — trading 13.6% above its estimated fair value. The current Debt-to-Equity is -0.71. Adiuvo Investments' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Adiuvo Investments (WAR:ADV), the current Debt-to-Equity is -0.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adiuvo Investments (WAR:ADV) Overvalued in 2026?
Based on GuruFocus' analysis, Adiuvo Investments stock appears to be overvalued.
The current stock price of zł0.53 is trading 13.6% above its estimated GF Value™ of zł0.47.
GuruFocus considers Adiuvo Investments to be Modestly Overvalued.
Key valuation signals for WAR:ADV:
Debt-to-Equity: -0.71
GF Value™: zł0.47 vs. price of zł0.53 (13.6% above fair value)
No single metric tells the full story. See the WAR:ADV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adiuvo Investments SA is engaged in the selection, development, financing and commercialization of projects in the international market. The new technologies developed by the company focus on disease management, monitoring healthy lifestyle and treatment with the help of mobile devices and supplementation and functional food, or food, which in addition to nutritional properties also has health properties.
26GF Score
Get the complete analysis for WAR:ADV
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ADV has been successfully added to your 
